VintaBio Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
VintaBio operates as a viral-vector development and manufacturing partner in the biotechnology research sector. It collaborates with biotech and pharmaceutical companies pursuing viral vector programs—including AAV, LVV, adenoviral, and Vero-based platforms—through the transition from early development to clinical testing. The company specializes in adherent manufacturing across preclinical work, IND-enabling studies, process development, and clinical-stage production, aiming to deliver scalable output with consistent quality. Headquartered in Philadelphia, in the Navy Yard district, the company sits in a region known for cell and gene therapy innovation. Recent activity includes presenting data at the ASGCT annual meeting in 2025 to illustrate the productivity of its VintaProcess approach.